Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application to market a generic oxycodone/acetaminophen product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone/Acetaminophen (oxycodone/acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)